Effectiveness of Interventional Therapy for Non-Flow-Limiting Vulnerable Plaques

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2190 participants.

Also called NCT06855537

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 2,190 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06855537
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06855537. Randomized; no masking; primary purpose prevention. Start 2025-11-03 (actual); primary completion 2027-09-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effectiveness of Interventional Therapy for Non-Flow-Limiting Vulnerable Plaques
Condition
Coronary Arterial Disease (CAD (coronary artery disease))
Condition
Vulnerable Coronary Plaques
Condition
Thin-cap fIbroatheroma
Condition
Acute Coronary Syndromes (ACS)
Intervention (Procedure)
PCI (percutaneous coronary intervention) strategy
Intervention (Drug)
OMT strategy
Lead sponsor
Beijing Anzhen Hospital (class: other)

Record details

Record id
cardio:ct-nct06855537
Content hash
2519044f0c60eb439c3002a4b88655d96ad88e5db1fc67e55307f779a0f02fbd